EFhd2/Swiprosin-1 is a common genetic determinator for sensation-seeking/low anxiety and alcohol addiction

Molecular Psychiatry

Volumn 23, Issue 5, 2018, Pages 1303-1319

  Mielenz, D ^a   Reichel, M ^b   Jia, T ^c   Quinlan, E B ^c   Stockl T ^b   Mettang, M ^b   Zilske, D ^b   Kirmizi Alsan, E ^b   Schonberger P ^b   Praetner, M ^b   Huber, S E ^b   Amato, D ^b   Schwarz, M ^d   Purohit, P ^a   Brachs, S ^e   Spranger, J ^e   Hess, A ^b   Buttner C ^b   Ekici, A B ^b   Perez Branguli, F ^b   Winner, B ^b   Rauschenberger, V ^b   Banaschewski, T ^f   Bokde, A L W ^g   Buchel C ^h   Conrod, P J ^i,j   Desrivieres S ^c   Flor, H ^f   Frouin, V ^k   Gallinat, J ^h   Garavan, H ^l   Gowland, P ^m   Heinz, A ⁿ   Martinot, J L ^o   Lemaitre, H ^o   Nees, F ^f   Paus, T ^p   Smolka, M N ^q   Schambony, A ^b   Bauerle T ^d   Eulenburg, V ^b   Alzheimer, C ^b   Lourdusamy, A ^r   Schumann, G ^c   Muller C P ^b   more..

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g TRINITY COLLEGE DUBLIN   (Ireland)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ UNIVERSITY OF MONTREAL   (Canada)

^j KING'S COLLEGE LONDON   (United Kingdom)

^k DIF   (France)

^l UNIVERSITY OF VERMONT   (United States)

^m UNIVERSITY OF NOTTINGHAM   (United Kingdom)

ⁿ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^o INSERM   (France)

^p ROTMAN RESEARCH INSTITUTE   (Canada)

^q DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^r UNIVERSITY OF NOTTINGHAM   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; EFHD2 PROTEIN, HUMAN; EFHD2 PROTEIN, MOUSE;

ADOLESCENT; ADULT; ALCOHOLISM; ANIMAL; ANXIETY; ANXIETY DISORDER; C57BL MOUSE; DRINKING BEHAVIOR; FEMALE; GENETICS; HIGH RISK BEHAVIOR; HUMAN; KNOCKOUT MOUSE; MALE; MOUSE; SINGLE NUCLEOTIDE POLYMORPHISM; XENOPUS LAEVIS;

ADOLESCENT; ADULT; ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; ANXIETY; ANXIETY DISORDERS; CALCIUM-BINDING PROTEINS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK-TAKING; XENOPUS LAEVIS;

EID: 85017515866     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2017.63     Document Type: Article

References (92)

1. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 655–679. DOI: 10.1016/j.euroneuro.2011.07.018
2. Ahmed SH. Toward an evolutionary basis for resilience to drug addiction. Behav Brain Sci 2011; 34: 310–311.
3. Müller CP, Schumann G. Drugs as instruments: a new framework for non-addictive psychoactive drug use. Behav Brain Sci 2011; 34: 293–310.
4. Müller CP, Homberg JR. The role of serotonin in drug use and addiction. Behav Brain Res 2015; 277C: 146–192.
5. Heath DB Drinking occasions: Comparative Perspectives on Alcohol and Culture. Brunner/Mazel: Philadelphia, USA, 2000.
6. Anderson P, Baumberg B Alcohol in Europe. Institute of Alcohol Studies: London, UK, 2006.
7. Wagner FA, Anthony JC. From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 2002; 26: 479–488.
8. Chen CY, Anthony JC. Epidemiological estimates of risk in the process of becoming dependent upon cocaine: cocaine hydrochloride powder versus crack cocaine. Psychopharmacology 2004; 172: 78–86.
9. Heyman GM. Resolving the contradictions of addiction. Behav Brain Sci 1996; 19: 561–610.
10. SAMSHA. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, Substance Abuse and Mental Health Services Administration, Rockville, MD, USA, 2014.
11. Chen J, Repunte-Canonigo V, Kawamura T, Lefebvre C, Shin W, Howell LL et al. Hypothalamic proteoglycan syndecan-3 is a novel cocaine addiction resilience factor. Nat Commun 2013; 4: 1955.
12. Morrow JD, Flagel SB. Neuroscience of resilience and vulnerability for addiction medicine: From genes to behavior. Prog Brain Res 2016; 223: 3–18.
13. Maclaren EJ, Sikela JM. Cerebellar gene expression profiling and eQTL analysis in inbred mouse strains selected for ethanol sensitivity. Alcohol Clin Exp Res 2005; 29: 1568–1579.
14. Vuadens F, Rufer N, Kress A, Corthesy P, Schneider P, Tissot JD. Identification of swiprosin 1 in human lymphocytes. Proteomics 2004; 4: 2216–2220.
15. Kroczek C, Lang C, Brachs S, Grohmann M, Dutting S, Schweizer A et al. Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts. J Immunol 2010; 184: 3665–3676.
16. Dütting S, Brachs S, Mielenz D. Fraternal twins: Swiprosin-1/EFhd2 and Swiprosin-2/EFhd1, two homologous EF-hand containing calcium binding adaptor proteins with distinct functions. Cell Commun Signal 2011; 9: 2.
17. Hagen S, Brachs S, Kroczek C, Furnrohr BG, Lang C, Mielenz D. The B cell receptor-induced calcium flux involves a calcium mediated positive feedback loop. Cell Calcium 2012; 51: 411–417.
18. Gu J, Lee CW, Fan Y, Komlos D, Tang X, Sun C et al. ADF/cofilin-mediated actin dynamics regulate AMPA receptor trafficking during synaptic plasticity. Nat Neurosci 2010; 13: 1208–1215.
19. Huh YH, Kim SH, Chung KH, Oh S, Kwon MS, Choi HW et al. Swiprosin-1 modulates actin dynamics by regulating the F-actin accessibility to cofilin. Cell Mol Life Sci 2013; 70: 4841–4854.
20. Kwon MS, Park KR, Kim YD, Na BR, Kim HR, Choi HJ et al. Swiprosin-1 is a novel actin bundling protein that regulates cell spreading and migration. PLoS ONE 2013; 8: e71626.
21. Mielenz D, Gunn-Moore F. Physiological and pathophysiological functions of Swiprosin-1/EFhd2 in the nervous system. Biochem J 2016; 473: 2429–2437.
22. Borger E, Herrmann A, Mann DA, Spires-Jones T, Gunn-Moore F. The calcium-binding protein EFhd2 modulates synapse formation in vitro and is linked to human dementia. J Neuropathol Exp Neurol 2014; 73: 1166–1182.
23. Purohit P, Perez-Branguli F, Prots I, Borger E, Gunn-Moore F, Welzel O et al. The Ca2+ sensor protein swiprosin-1/EFhd2 is present in neurites and involved in kinesin-mediated transport in neurons. PLoS ONE 2014; 9: e103976.
24. Vega IE, Traverso EE, Ferrer-Acosta Y, Matos E, Colon M, Gonzalez J et al. A novel calcium-binding protein is associated with tau proteins in tauopathy. J Neurochem 2008; 106: 96–106.
25. Ferrer-Acosta Y, Rodriguez-Cruz EN, Orange F, De Jesus-Cortes H, Madera B, Vaquer-Alicea J et al. EFhd2 is a novel amyloid protein associated with pathological tau in Alzheimer's disease. J Neurochem 2013; 125: 921–931.
26. Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Maccarrone G, Dias-Neto E et al. Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2009; 259: 151–163.
27. Zuckerman M. The psychobiological model for impulsive unsocialized sensation seeking: a comparative approach. Neuropsychobiology 1996; 34: 125–129.
28. Schwarting RK, Thiel CM, Müller CP, Huston JP. Relationship between anxiety and serotonin in the ventral striatum. Neuroreport 1998; 9: 1025–1029.
29. Norbury A, Husain M. Sensation-seeking: dopaminergic modulation and risk for psychopathology. Behav Brain Res 2015; 288: 79–93.
30. Brachs S, Turqueti-Neves A, Stein M, Reimer D, Brachvogel B, Bosl M et al. Swiprosin-1/EFhd2 limits germinal center responses and humoral type 2 immunity. Eur J Immunol 2014; 44: 3206–3219.
31. Stacey D, Bilbao A, Maroteaux M, Jia T, Easton AC, Longueville S et al. RASGRF2 regulates alcohol-induced reinforcement by influencing mesolimbic dopamine neuron activity and dopamine release. Proc Natl Acad Sci USA 2012; 109: 21128–21133.
32. Easton AC, Lucchesi W, Lourdusamy A, Lenz B, Solati J, Golub Y et al. alphaCaMKII autophosphorylation controls the establishment of alcohol drinking behavior. Neuropsychopharmacology 2013; 38: 1636–1647.
33. Zheng F, Puppel A, Huber SE, Link AS, Eulenburg V, van Brederode JF et al. Activin controls ethanol potentiation of inhibitory synaptic transmission through GABA receptors and concomitant behavioral sedation. Neuropsychopharmacology 2016; 41: 2024–2033.
34. Easton AC, Lucchesi W, Schumann G, Giese KP, Müller CP, Fernandes C. alphaCaMKII autophosphorylation controls exploratory activity to threatening novel stimuli. Neuropharmacology 2011; 61: 1424–1431.
35. Süss P, Kalinichenko L, Baum W, Reichel M, Kornhuber J, Loskarn S et al. Hippocampal structure and function are maintained despite severe innate peripheral inflammation. Brain Behav Immun 2015; 49: 156–170.
36. Yeung M, Lu L, Hughes AM, Treit D, Dickson CT. FG7142, yohimbine, and betaCCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta. Neuropharmacology 2013; 75: 47–52.
37. Amato D, Natesan S, Yavich L, Kapur S, Müller CP. Dynamic regulation of dopamine and serotonin responses to salient stimuli during chronic haloperidol treatment. Int J Neuropsychopharmacol 2011; 14: 1327–1339.
38. Easton AC, Lucchesi W, Mizuno K, Fernandes C, Schumann G, Giese KP et al. alphaCaMKII autophosphorylation controls the establishment of alcohol-induced conditioned place preference in mice. Behav Brain Res 2013; 252: 72–76.
39. Cunningham CL, Gremel CM, Groblewski PA. Drug-induced conditioned place preference and aversion in mice. Nat Protoc 2006; 1: 1662–1670.
40. Müller CP, De Souza Silva MA, Huston JP. Double dissociating effects of sensory stimulation and cocaine on serotonin activity in the occipital and temporal cortices. Neuropharmacology 2007; 52: 854–862.
41. Pum M, Carey RJ, Huston JP, Müller CP. Dissociating effects of cocaine and d-amphetamine on dopamine and serotonin in the perirhinal, entorhinal, and prefrontal cortex of freely moving rats. Psychopharmacology 2007; 193: 375–390.
42. Franklin KBJ, Paxionos G The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego, USA, 1997.
43. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402–408.
44. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249–264. DOI: 10.1093/biostatistics/4.2.249
45. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.
46. Stacey D, Lourdusamy A, Ruggeri B, Maroteaux M, Jia T, Cattrell A et al. A translational systems biology approach in both animals and humans identifies a functionally related module of accumbal genes involved in the regulation of reward processing and binge drinking in males. J Psychiatry Neurosci 2015; 41: 150138.
47. Schumann G, Loth E, Banaschewski T, Barbot A, Barker G, Büchel C et al. The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatr 2010; 15: 1128–1139.
48. Morgan M, Hibell B, Andersson B, Bjarnason T, Kokkevi A, Narusk A. The ESPAD study: implications for prevention. Drug Educ Prev Policy 1999; 6: 243–256.
49. Woicik PA, Stewart SH, Pihl RO, Conrod PJ. The Substance Use Risk Profile Scale: a scale measuring traits linked to reinforcement-specific substance use profiles. Addict Behav 2009; 34: 1042–1055.
50. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.
51. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904–909.
52. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010; 34: 816–834.
53. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 2012; 44: 955–959.
54. Nieuwkoop PD, Faber J. External and internal stage criteria in the development of Xenopus laevis. Normal Tables of Xenopus laevis, 1975; 162–188.
55. Harland RM. In situ hybridization: an improved whole-mount method for Xenopus embryos. Methods Cell Biol 1991; 36: 685–695.
56. Avramidou A, Kroczek C, Lang C, Schuh W, Jack HM, Mielenz D. The novel adaptor protein Swiprosin-1 enhances BCR signals and contributes to BCR-induced apoptosis. Cell Death Differ 2007; 14: 1936–1947.
57. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550–553.
58. Ramsey PH. Multiple comparisons of independent means. In: Edwards LK (ed.). Applied Analysis of Variance in Behavioral Science. Marcel Dekker: New York, USA, 1993; p 25–61.
59. Lenz B, Müller CP, Stoessel C, Sperling W, Biermann T, Hillemacher T et al. Sex hormone activity in alcohol addiction: integrating organizational and activational effects. Prog Neurobiol 2012; 96: 136–163.
60. Piazza PV, Deminiere JM, Le Moal M, Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989; 245: 1511–1513.
61. Stautz K, Cooper A. Impulsivity-related personality traits and adolescent alcohol use: a meta-analytic review. Clin Psychol Rev 2013; 33: 574–592.
62. Whelan R, Watts R, Orr CA, Althoff RR, Artiges E, Banaschewski T et al. Neuropsychosocial profiles of current and future adolescent alcohol misusers. Nature 2014; 512: 185–189.
63. Peritogiannis V. Sensation/novelty seeking in psychotic disorders: a review of the literature. World J Psychiatry 2015; 5: 79–87.
64. Blanchard MM, Mendelsohn D, Stamp JA. The HR/LR model: Further evidence as an animal model of sensation seeking. Neurosci Biobehav Rev 2009; 33: 1145–1154.
65. Magid V, Maclean MG, Colder CR. Differentiating between sensation seeking and impulsivity through their mediated relations with alcohol use and problems. Addict Behav 2007; 32: 2046–2061.
66. White NM. Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction 1996; 91: 921–949.
67. Huston JP, Silva MA, Topic B, Müller CP. What's conditioned in conditioned place preference? Trends Pharmacol Sci 2013; 34: 162–166.
68. Spanagel R. Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev 2009; 89: 649–705.
69. Streicher WW, Lopez MM, Makhatadze GI. Modulation of quaternary structure of S100 proteins by calcium ions. Biophys Chem 2010; 151: 181–186.
70. Fukuda M, Mikoshiba K. Doc2gamma, a third isoform of double C2 protein, lacking calcium-dependent phospholipid binding activity. Biochem Biophys Res Commun 2000; 276: 626–632.
71. Verheij MM, Cools AR. Twenty years of dopamine research: individual differences in the response of accumbal dopamine to environmental and pharmacological challenges. Eur J Pharmacol 2008; 585: 228–244.
72. Sansom SN, Griffiths DS, Faedo A, Kleinjan DJ, Ruan Y, Smith J et al. The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis. PLoS Genet 2009; 5: e1000511.
73. Sessa A, Mao CA, Colasante G, Nini A, Klein WH, Broccoli V. Tbr2-positive intermediate (basal) neuronal progenitors safeguard cerebral cortex expansion by controlling amplification of pallial glutamatergic neurons and attraction of subpallial GABAergic interneurons. Genes Dev 2010; 24: 1816–1826.
74. Yogarajah M, Matarin M, Vollmar C, Thompson PJ, Duncan JS, Symms M et al. PAX6, brain structure and function in human adults: advanced MRI in aniridia. Ann Clin Transl Neurol 2016; 3: 314–330.
75. Quinn JC, Molinek M, Martynoga BS, Zaki PA, Faedo A, Bulfone A et al. Pax6 controls cerebral cortical cell number by regulating exit from the cell cycle and specifies cortical cell identity by a cell autonomous mechanism. Dev Biol 2007; 302: 50–65.
76. Elsen GE, Hodge RD, Bedogni F, Daza RA, Nelson BR, Shiba N et al. The protomap is propagated to cortical plate neurons through an Eomes-dependent intermediate map. Proc Natl Acad Sci USA 2013; 110: 4081–4086.
77. Díaz-Alonso J, Aguado T, de Salas-Quiroga A, Ortega Z, Guzmán M, Galve-Roperh I. CB1 cannabinoid receptor-dependent activation of mTORC1/Pax6 signaling drives Tbr2 expression and basal progenitor expansion in the developing mouse cortex. Cereb Cortex 2015; 25: 2395–2408.
78. Moreno N, Rétaux S, González A. Spatio-temporal expression of Pax6 in Xenopus forebrain. Brain Res 2008; 1239: 92–99.
79. Wilson S, Malone SM, Thomas KM, Iacono WG. Adolescent drinking and brain morphometry: a co-twin control analysis. Dev Cogn Neurosci 2015; 16: 130–138.
80. Robinson TE, Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004; 47: 33–46.
81. Zhou FC, Anthony B, Dunn KW, Lindquist WB, Xu ZC, Deng P. Chronic alcohol drinking alters neuronal dendritic spines in the brain reward center nucleus accumbens. Brain Res 2007; 1134: 148–161.
82. Heinz A, Higley JD, Gorey JG, Saunders RC, Jones DW, Hommer D et al. In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates. Am J Psychiatry 1998; 155: 1023–1028.
83. Hinckers AS, Laucht M, Schmidt MH, Mann KF, Schumann G, Schuckit MA et al. Low level of response to alcohol as associated with serotonin transporter genotype and high alcohol intake in adolescents. Biol Psychiatry 2006; 60: 282–287.
84. Nadal R, Armario A, Janak PH. Positive relationship between activity in a novel environment and operant ethanol self-administration in rats. Psychopharmacology 2002; 162: 333–338.
85. Samaha AN, Robinson TE. Why does the rapid delivery of drugs to the brain promote addiction? Trends Pharmacol Sci 2005; 26: 82–87.
86. Yau WY, Zubieta JK, Weiland BJ, Samudra PG, Zucker RA, Heitzeg MM. Nucleus accumbens response to incentive stimuli anticipation in children of alcoholics: relationships with precursive behavioural risk and lifetime alcohol use. J Neurosci 2012; 32: 2544–2551.
87. Hooks MS, Colvin AC, Juncos JL, Justice J-BJ. Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis. Brain Res 1992; 587: 306–312.
88. Leyton M, Boileau I, Benkelfat C, Diksic M, Baker G, Dagher A. Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology 2002; 27: 1027–1035.
89. Müller CP. Episodic memories and their relevance for psychoactive drug use and addiction. Front Behav Neurosci 2013; 7: 34.
90. Zweifel LS, Argilli E, Bonci A, Palmiter RD. Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviours. Neuron 2008; 59: 486–496.
91. McBride WJ, Murphy JM, Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 1999; 101: 129–152.
92. Schumann G, Johann M, Frank J, Preuss U, Dahmen N, Laucht M et al. Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior. Arch Gen Psychiatry 2008; 65: 826–838.